European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Heart Valve Disease
Interventions
OTHER

Decellularized human valves

Trial Locations (8)

2004

"Universitatea de Stat de Medicina si Farmacie Nicolae Testemitanu, SMPHU", Chisinau

2333

Leids Universitair Medisch Centrum, LUMC, Leiden

3000

Universitair Ziekenhuis Leuven, UZL, Leuven

8032

Universitaet Zuerich, UZH, Switzerland, Zurich

30625

Hannover Medical School, Hanover

35128

Università degli studi di Padova, Azienda Ospedaliera di Padova, UNIPD/AOP, Padua

75015

Université Paris Descartes, UPD, Paris

WC1N 3JH

Great Ormond Street Hospital for Children NHS Trust, GOSH, London

All Listed Sponsors
collaborator

Hannover Medical School

OTHER

collaborator

State University of Medicine and Pharmaceutics, Chisinau, Moldavia

UNKNOWN

collaborator

Leiden University Medical Center

OTHER

collaborator

Great Ormond Street Hospital for Children NHS Foundation Trust

OTHER

collaborator

University of Padova

OTHER

collaborator

Hôpital Necker-Enfants Malades

OTHER

collaborator

University of Zurich

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

German Society for Tissue Transplantation

OTHER

collaborator

European Homograft Bank

OTHER

collaborator

Gottfried Wilhelm Leibniz Universität Hannover

OTHER

lead

corlife

INDUSTRY

NCT02035540 - European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR | Biotech Hunter | Biotech Hunter